Advertisement

GLP-1s

FDA has announced it has expanded the approved use of Humira (adalimumab), manufactured by Abbott Laboratories, to include treatment of moderate-to-severe ulcerative colitis in adults, according to a news release.

Advertisement

Oral cavity, oral pharyngeal and salivary gland cancers may be the costliest cancers to treat in the United States, according to a study in Head & Neck Oncology.

Advertisement